• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION VERCISE? CARTESIA?; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION CORPORATION VERCISE? CARTESIA?; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number DB-2202-45
Medical Device Problem Code Unexpected Therapeutic Results (1631)
Health Effect - Clinical Code Shaking/Tremors (2515)
Date of Event 04/14/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device db-2202-45, serial number: (b)(6) was not returned to boston scientific for analysis and the complaint as reported was not able to be confirmed.A review of the device history record (dhr) confirmed that the device met specifications prior to shipping.No manufacturing deviations were noted that could have contributed to the event reported.The labelled indications, instructions for use warns against the stimulator orientation: orient the stimulator parallel to the skin surface.Suboptimal placement of the stimulator may result in a revision surgery.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of: adverse event related to procedure additional pro code selection that applies to the indication of this device .
 
Event or Problem Description
It was reported that during the deep brain stimulation (dbs) procedure, the physician positioned the lead based on intraoperative testing and imaging.Once placed, the surgeon confirmed the final position.However, at a postoperative imaging, revealed that the lead had been misplaced, resulting in inadequate stimulation.To correct this, the patient underwent a revision procedure in which the lead was removed and replaced.Following the revision, the patient made a full recovery.In accordance with facility policy, the explanted device was disposed of and will not be returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE? CARTESIA?
Common Device Name
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key25112953
Report Number3006630150-2026-02941
Device Sequence Number13092933
Product Code MHY
UDI-Device Identifier08714729905288
UDI-Public(01)08714729905288(17)271217(10)7147128
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
P150031
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Device Explanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/07/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7147128
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/14/2026
Initial Report FDA Received Date05/07/2026
Date Device Manufactured12/17/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age62 YR
Patient SexMale
-
-